Suppr超能文献

免疫测定的CNR外部质量评估计划:参与者的统计分析与报告

The CNR external quality assessment program for immunoassays: statistical analysis and reports for participants.

作者信息

Pilo A, Zucchelli G C, Chiesa M R, Masini S, Clerico A

机构信息

Istituto di Fisiologia Clinica, CNR, Pisa.

出版信息

Ann Ist Super Sanita. 1991;27(3):469-77.

PMID:1809067
Abstract

The results collected in the CNR/Tecno-standard external quality assessment (EQA) program for immunoassays of hormones and tumor markers are computer-processed to prepare a "periodic" report and an "end-of-period" report to be sent back to the participants in the survey. The aim of the periodic report is to allow comparison between the result obtained by a laboratory on a single EQA sample with those of all the other laboratories and with the users of the same method/kit; the report contains a histogram of all results and the mean, SD, CV, median and range (computed after trimming of outliers). The same statistics are also reported for data grouped according to the method/kit used. The end of period report provide the participant with a scored estimate of individual analytical performance (average bias and average imprecision) achieved assaying all the EQA samples dispatched in the control cycle (usually a six-month period during which 12-18 samples have been assayed); this cumulative report contains estimates of the performance of those kits more widely used in the survey. Beside helping laboratories to monitor their performance against an external reference, the EQA allows the collection of a large amount of data from which the state of the art and trends in the quality of immunoassays can be soundly evaluated and documented. To achieve this aim, the average total variability is computed from all data collected in the EQA cycle; this index is used for comparing the between-laboratory agreement of different immunoassays and for demonstrating trends of the quality over time.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在用于激素和肿瘤标志物免疫测定的CNR/Tecno标准外部质量评估(EQA)计划中收集的结果会进行计算机处理,以编制一份“定期”报告和一份“期末”报告,并发送给调查参与者。定期报告的目的是使一个实验室在单个EQA样本上获得的结果能够与所有其他实验室以及使用相同方法/试剂盒的用户的结果进行比较;该报告包含所有结果的直方图以及均值、标准差、变异系数、中位数和范围(在剔除异常值后计算得出)。对于根据所使用的方法/试剂盒分组的数据,也会报告相同的统计数据。期末报告为参与者提供对在控制周期(通常为六个月,在此期间已检测12 - 18个样本)内检测所有EQA样本所取得的个体分析性能(平均偏差和平均不精密度)的评分估计;这份累积报告包含了在调查中使用较为广泛的那些试剂盒的性能估计。除了帮助实验室对照外部参考标准监测其性能外,EQA还允许收集大量数据,从中可以合理评估和记录免疫测定的技术水平和质量趋势。为实现这一目标,从EQA周期中收集的所有数据计算平均总变异性;该指标用于比较不同免疫测定之间的实验室间一致性,并展示质量随时间的趋势。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验